Hemodialysis and protein oxidation products

Annals of the New York Academy of Sciences

Volumn 1100, Issue , 2007, Pages 404-408

  Coşkun, Cihan ^a   Kural, Alev ^a   Döventaş, Yasemin ^a   Koldaş, Macit ^a   Özturk, Hümeyra ^a   Inal, Berrin Berçik ^a   Gümüş, Alper ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

AGE; AOPP; Hemodialysis; High flux dialyzer; Non highflux dialyzer

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED OXIDATION PROTEIN PRODUCT; PROTEIN; UNCLASSIFIED DRUG; CROSS LINKING REAGENT; DITYROSINE; DRUG DERIVATIVE; OXYGEN; REACTIVE OXYGEN METABOLITE; TYROSINE;

ADULT; AGED; CELL ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; IMMUNOCOMPETENT CELL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MONOCYTE; NEUTROPHIL; OXIDATION; ARTICLE; CHEMISTRY; CHRONIC KIDNEY FAILURE; INFLAMMATION; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS;

ADULT; AGED; AGED, 80 AND OVER; CROSS-LINKING REAGENTS; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MONOCYTES; NEUTROPHILS; OXIDATIVE STRESS; OXYGEN; PROTEINS; REACTIVE OXYGEN SPECIES; TYROSINE;

EID: 34249723601     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1395.045     Document Type: Conference Paper

References (9)

1. DESCAMPS-LATSCHA, B. & V. WITKO- SARSAT. 2001. Importance of oxidatively modified proteins in chronic renal failure. Kidney Int. 59(Suppl 78): S108-S113.
2. KITIYAKARA, C., J. GONIN, Z. MASSY & C.S. WILCOX. 2000. Non-traditional cardiovascular disease risk factors in end stage renal disease: oxidative stress and hyperhomocysteinemia. Curr. Opin. Nephrol. Hyperten. 9: 477-487.
3. AMORE, A. & R. COPPO. 2002. Immunological basis of inflammation in dialysis. Nephrol. Dial. Transplant. 17(Suppl 8): 16-24.
4. NGUYEN-KHOA, T., Z.A. MASSY, P.J. DE BANDT, et al. 2001. Oxidative stress and hemodialysis: role of dialysis treatment. Nephrol. Dial. Transplant. 16: 335-340.
5. WARD, R.A., R. OUSEPH & K.R. MCLEISH. 2003. Effects of high-flux hemodialysis on oxidant stress.. Kidney Int. 63: 353-359.
6. WITKO-SARSAT, V., M. FRIENDLANDER, C. CAPEILLERE-BLANDIN, et al. 1996. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49: 1304-1313.
7. MASSY, Z.A., T. NGUYEN-KHOA & C.H. BEAUVAIS. 2002. Oxidative stress and chronic renal failure: markers and management. J. Nephrol. 15: 336-341.
8. MIYATA, T., S. SUGIYAMA, A. SAITO & K. KUROKAWA. 2001. Reactive carbonyl compounds related uremic toxicity (carbonyl stress). Kidney Int. 59: 25-31.
9. WAGNER, Z., I. WITTMAN & I. MAZAK. 2001. Carboxymethyllysine levels in patients with type 2 diabetes: role of renal function. Am. J. Kidney Dis. 785-791.